Metformin FDC [Regulatives / Guidelines]

posted by MaggieSantos – Portugal, 2015-09-25 21:39 (3128 d 21:39 ago) – Posting: # 15472
Views: 3,331

Dear Sirs:

I have to evaluate BE for sitagliptin plus metformin FDC formulations (50/1000 and 50/850) as well as for vildagliptin plus metformin FDC (50/850 and 50/1000).

Concerning the guideline on investigation of bioequivalence could I waive BE for the lower strenght, assuming the a) and b) requirements?

Kind Regards

Margarida Barreto

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,661 registered users;
89 visitors (0 registered, 89 guests [including 5 identified bots]).
Forum time: 19:18 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5